During the past decade, LLC Diaservis conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LLC Diaservis" are "Asthma" (1 trials), "Crohn Disease" (1 trials), "Follicular Lymphoma" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "LLC Diaservis" in a lesser frequency.

Most popular intervention types in "LLC Diaservis" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "Placebo" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Etrolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "LLC Diaservis" are 4 trials for "All" genders.

Currently, there are NaN active trials in "LLC Diaservis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in LLC Diaservis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LLC Diaservis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".